The ROADSTER 2 Study is a follow up to the ROADSTER Study, which evaluated the TCAR Procedure in 219 patients at high risk for complications from surgery. The results from the ROADSTER Study were published in the Journal of Vascular Surgery in November 2015.
The ROADSTER 2 Study enrolled 600+ patients who were treated with the TCAR Procedure using the ENROUTE® Transcarotid Neuroprotection and ENROUTE® Transcarotid Stent System. ROADSTER 2 completed enrollment on April 29, 2019. Please refer back to this web page in the future for the results of the ROADSTER2 study.